UBS Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $12K | Buy |
|
|||||
|
2024
Q4 | $2.11K | Buy |
|
|||||
|
2024
Q3 | $26 | Sell |
|
|||||
|
2024
Q2 | $49.4K | Buy |
|
|||||
|
2024
Q1 | $49 | Sell |
|
|||||
|
2023
Q4 | $1.97K | Buy |
|
|||||
|
2023
Q3 | $744 | Sell |
|
|||||
|
2023
Q2 | $4.45K | Buy |
|
|||||
|
2023
Q1 | $1.12K | Sell |
|
|||||
|
2022
Q4 | $8.2K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $4K | Buy |
|
|||||
|
2022
Q1 | $0 | Hold |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $6K | Sell |
|
|||||
|
2021
Q2 | $26K | Buy |
|
|||||
|
2021
Q1 | $46K | Sell |
|
|||||
|
2020
Q4 | $236K | Buy |
|
|||||
|
2020
Q3 | $155K | Sell |
|
|||||
|
2020
Q2 | $178K | Buy |
|
|||||
|
2020
Q1 | $109K | Buy |
|
|||||
|
2019
Q4 | $89K | Buy |
|
|||||
|
2019
Q3 | $59K | Buy |
|
|||||
|
2019
Q2 | $28K | Buy |
|
|||||
|
2019
Q1 | $15K | Sell |
|
|||||
|
2018
Q4 | $36K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $7K | Buy |
|
|||||
|
2018
Q1 | $14K | Buy |
|